Companies: 10,795·Total market cap: $144.5T
Liminal BioSciences Inc.

Liminal BioSciences Inc.

LMNLNASDAQHealthcare
$8.50
+$0.01(+0.12%)
Market Cap$27621005
P/E Ratio—
52W High$8.5
52W Low$3.1
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Liminal BioSciences Inc. (LMNL) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001351172 · LMNL · NASDAQ · as of Jun 9, 2026

Filing snapshot

174
Total Filings
15-12G
Latest Form
2023-10-06
Most Recent
2009
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001351172 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2023-03-15
Fiscal Year End
Mar 15, 2023
Accession No.
0000950170-23-008141
Primary Document
lmnl-20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001351172 · Accession 0000950170-23-008141

Latest Key Filings

6-KQuarterly Report
6-K
2023-09-26
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2023-10-06
View
SC 13D/ASC 13D/A
SC 13D/A
2023-09-27
View
EFFECTEFFECT
EFFECT
2023-09-26
View
EFFECTEFFECT
EFFECT
2023-09-26
View
EFFECTEFFECT
EFFECT
2023-09-26
View
POS AMPOS AM
POS AM
2023-09-26
View
25-NSE25-NSE
25-NSE
2023-09-26
View
POS AMPOS AM
POS AM
2023-09-26
View
POS AMPOS AM
POS AM
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-09-26
View
SC 13E3/ASC 13E3/A
SC 13E3/A
2023-09-26
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-09-26
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-09-19
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-09-15
View
Showing 1–15 of 174 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001351172  |  Exchange: NASDAQ · Healthcare

Liminal BioSciences Inc. (NASDAQ: LMNL) has submitted 174 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2009. As a Healthcare sector company with CIK 0001351172, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Liminal BioSciences Inc.'s most comprehensive regulatory disclosure. The most recent Liminal BioSciences Inc. 10-K was filed on 2023-03-15 for fiscal year ending 2023. Historical LMNL 10-K annual reports are available from 2006 through 2023.

Investors researching Liminal BioSciences Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
IRD SEC Filings →MRNS SEC Filings →ANGN SEC Filings →ALLK SEC Filings →FRLN SEC Filings →ANPC SEC Filings →LSB SEC Filings →SER SEC Filings →
→ LMNL Financials→ LMNL Earnings→ LMNL Insider Trades

Frequently Asked Questions

LMNL SEC Filings · 8 questions

Liminal BioSciences Inc. (LMNL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 174 filings and access original documents at no cost. Liminal BioSciences Inc.'s CIK is 0001351172.

LMNL SEC filingsLiminal BioSciences Inc. SEC documentsfind LMNL 10-K